PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables

J Clin Pathol. 1992 May;45(5):416-9. doi: 10.1136/jcp.45.5.416.

Abstract

Aims: To investigate the expression of two cell cycle related antigens (proliferating cell nuclear antigen (PCNA) and Ki67 related antigen) in a series of breast cancers; and the possible correlations between the PCNA and Ki67 labelling indexes (PCNA-LI and Ki67-LI) and their associations with other biological and clinicopathological variables.

Methods: Ninety six ductal and 10 lobular carcinoma specimens were investigated. Samples were fixed in formalin and in Methacarnoy for localisation of PCNA. Ki67 was immunostained on frozen sections. The PCNA-LI and Ki67-LI were evaluated in relation to tumour size, mitotic count, histological grade, nodal state as well as receptor content and altered expression of the p53 gene.

Results: PCNA-LI did not correlate with Ki67-LI, nor was it associated with any other variable examined. A high KI67-LI (above the median value of 13.5) was associated with high grade and mitotic count, negative receptor content, and altered expression of the p53 gene, but not with other variables.

Conclusions: The PCNA-LI does not seem to be a substitute for the Ki67-LI in evaluating the growth fraction in breast cancer.

MeSH terms

  • Antigens, Neoplasm / analysis*
  • Breast Neoplasms / chemistry
  • Breast Neoplasms / immunology*
  • Breast Neoplasms / pathology
  • Humans
  • Ki-67 Antigen
  • Lymphatic Metastasis
  • Mitotic Index
  • Nuclear Proteins / analysis*
  • Proliferating Cell Nuclear Antigen
  • Receptors, Estrogen / analysis
  • Receptors, Progesterone / analysis
  • Tumor Suppressor Protein p53 / analysis

Substances

  • Antigens, Neoplasm
  • Ki-67 Antigen
  • Nuclear Proteins
  • Proliferating Cell Nuclear Antigen
  • Receptors, Estrogen
  • Receptors, Progesterone
  • Tumor Suppressor Protein p53